Jack KelloggAvatar

Madrigal’s Surge: Breakthrough in Liver Treatment?

0
On Thursday, Madrigal Pharmaceuticals Inc. stocks have been trading up by 11.21 percent, amid innovation and analyst upgrades. Live Update At 14:32:50 EST: On Wednesday,...
Breast cancer breakthrough as new test could revolutionise treatment’

Breast cancer breakthrough as new test could revolutionise treatment’

0
Your support helps us to tell the storyFrom reproductive rights to climate change to Big Tech, The Independent is on the ground when the...
#

Precision Medicine Breakthroughs: Advancements in Healthcare Technology

0
ChatGPT said: Precision medicine leverages genomics, AI, biomarkers, and gene-editing to deliver personalized treatments. Emerging tools like CRISPR, liquid... Source link
Article Image

Breakthrough Discovery in Brain Stem Cell Study

0
A collaborative study conducted by QIMR Berghofer and London’s Francis Crick Institute explored the resting state of brain stem cells.Scientists identified how brain stem...
Frontiers | Diagnostic challenges and treatment breakthroughs in Malassezia restricta-induced meningoencephalitis: a real-world analysis of early mNGS applications

Frontiers | Diagnostic challenges and treatment breakthroughs in Malassezia restricta-induced meningoencephalitis:...

0
BackgroundMalassezia restricta is a lipid-dependent yeast species that commonly colonizes human and warm-blooded animal skin as an opportunistic pathogen. Al... Source link
T-DXd Granted Breakthrough Therapy Designation by FDA in HER2+ Breast Cancer

T-DXd Granted Breakthrough Therapy Designation by FDA in HER2+ Breast Cancer

0
The median PFS per BICR was 40.7 months in the T-DXd arm vs 26.9 months in the THP arm, for a difference of about...
Portsmouth Herald Subscription Offers, Specials, and Discounts

Science runs on serendipity, but federal cuts could make our luck...

0
A professor at Cornell University, a Jacksonville native, describes how luck plays a role in scientific advancement — but so does steady funding. Source link...
FDA Grants Breakthrough Therapy Designation to Frontline T-DXd Plus Pertuzumab in HER2+ Metastatic Breast Cancer

FDA Grants Breakthrough Therapy Designation to Frontline T-DXd Plus Pertuzumab in...

0
The FDA has granted breakthrough therapy designation to fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) in combination with pertuzumab for the first-line treatment of adult patients with...

Recent Posts